The most common mutations found in breast cancer are reported regardless of homozygosity or heterozygosity at TP53 (44–47%), PIK3CA (25–26%), CDH1 (21–22%), PTEN (5–6%), and CDKN2A (4–5%) [56]. Here, TP53 is linked to breast cancer.